Nanosphere (NSPH) Higher; Wins FDA Approval of Test for Bacteria in Bloodstream
Tweet Send to a FriendGet Alerts NSPH Hot Sheet
Trade NSPH Now!
Nanosphere (Nasdaq: NSPH) shares are higher following headlines it won FDA approval of test for bacteria in bloodstream.
Shares are 8 percent better on the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Shares are 8 percent better on the session.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Amarin's (AMRN) Vascepa Not in FDA Orange Book for April
- Alnylam (ALNY) Updates on Preclinical Data for RNAi Program Targeting ALAS-1
- Notable Winners and Losers from Q1 Earnings Season: (YRCW) (TSLA) (AVEO) (CRMB)
Create E-mail Alert Related Categories
FDA, Insiders' Blog
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
